BIO-CONVERT A/S: Financial statements 2023
CVR: 39842319
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIO-CONVERT A/S (CVR 39842319) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -18,160 and a net result of DKK -18,592 compared with DKK -15,230 the year before. Equity in the 2023 report amounted to DKK 319,253. The solvency ratio was 71%.
- Gross Profit
- DKK -18,160
- Profit/Loss
- DKK -18,592
- Equity
- DKK 319,253
- Total Assets
- DKK 449,638
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -18K | -19K | 319K | 0 |
| 2022 | - | -15K | -15K | -62K | 0 |
| 2021 | - | -3K | -24K | -47K | - |
| 2020 | - | 143K | 109K | -23K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 14, 2023, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of BIO-CONVERT A/S.
As of November 14, 2023, Christian Torben Hill-Madsen has joined the board of directors of BIO-CONVERT A/S.
As of November 14, 2023, Samia Sofie Kappe has joined the board of directors of BIO-CONVERT A/S.
As of November 14, 2023, Allan Traugott Wehnert has joined the board of directors of BIO-CONVERT A/S.
As of November 14, 2023, Tom Glæsner Larsen is registered as director of BIO-CONVERT A/S.
As of November 14, 2023, Christian Torben Hill-Madsen has stepped down as director of BIO-CONVERT A/S.
On November 14, 2023, the company changed its name from Nordicare Danmark ApS to BIO-CONVERT ApS.
BIO-CONVERT A/S has published its annual report for 2022. Gross profit came to DKK -15,230, and the net result was DKK -15,230.
On March 6, 2023, the company changed its name from Life Science Power House ApS to Nordicare Danmark ApS.
About BIO-CONVERT A/S
BIO-CONVERT A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named BIO-CONVERT ApS and Nordicare Danmark ApS. The management consists of Allan Traugott Wehnert. The board consists of Peter Severin Bach (chair), Christian Torben Hill-Madsen and Henrik Rouf. The company is owned by Nordicus Partners Corporation. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK -621,998 and a net result of DKK -587,511. Equity in the 2026 report amounted to DKK 2,607,707.